Subchronic administration of N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine (BD1047) alters σ1 receptor binding

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 39-47

  Zambon, Alexander C ^a   De Costa, Brian R ^b   Kanthasamy, Anumantha G ^a   Nguyen, Bang Q H ^a   Matsumoto, Rae R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Receptor; (+) Pentazocine; Cytotoxicity; Desensitization; Internalization; Regulation

Indexed keywords

ETHYLENEDIAMINE DERIVATIVE; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; PENTAZOCINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOTOXICITY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HISTOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MEMBRANE BINDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BINDING, COMPETITIVE; BRAIN; CELL MEMBRANE; CEREBROSPINAL FLUID; DOWN-REGULATION; ETHYLENEDIAMINES; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INFUSION PUMPS; INJECTIONS, INTRAVENTRICULAR; ISOTOPE LABELING; LIGANDS; MALE; NISSL BODIES; OSMOLAR CONCENTRATION; PENTAZOCINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; TRITIUM;

EID: 0031564635     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00053-8     Document Type: Article

References (38)

1. 3H]-(+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors, Mol. Neuropharmacol. 3, 117.
2. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
3. Contreras, P.C., D.M. Ragan, M.E. Bremer, T.H. Lanthorn, N.M. Gray, S. Iyengar, A.E. Jacobson, K.C. Rice and B.R. De Costa, 1991, Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil, Brain Res. 546, 79.
4. Creese, I. and S.H. Snyder, 1980, Chronic neuroleptic treatment and dopamine receptor regulation, Adv. Biochem. Psychopharmacol. 24, 89.
5. De Costa, B.R., L. Radesca, L. Di Paolo and W.D. Bowen, 1992, Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor, J. Med. Chem. 35, 38.
6. Goldstein, S.R., R.R. Matsumoto, T.L. Thompson, R.L. Patrick, W.D. Bowen and J.M. Walker, 1989, Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons, Synapse 4, 254.
7. Itzhak, Y., D. Mash, S.-H. Zhang and I. Stein 1991a, Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and σ ligands on MPTP and σ binding sites, Mol. Pharmacol. 39, 385.
8. Itzhak, Y., I. Stein, S.-H. Zhang, C.O. Kassim and D. Cristante, 1991b, Binding of σ ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of σ-receptor subtypes, J. Pharmacol. Exp. Ther. 257, 141.
9. Kenakin, T., 1993, Pharmacologic Analysis of Drug-Receptor Interaction, 2nd edn. (Raven Press, New York, NY).
10. 3H]dextromethorphan and sigma ligands to guinea pig brain, Life Sci. 48, 543.
11. Kurlan, R. and I. Shoulson, 1982, Up and down regulation: clinical significance of nervous system receptor-drug interactions, Clin. Neuropharmacol. 5, 345.
12. Largent, B.L., H. Wikström, A.L. Gundlach and S.H. Snyder, 1987, Structural determinants of σ receptor affinity, Mol. Pharmacol. 32, 772.
13. Largent, B.L., H. Wikström, A.M. Snowman and S.H. Snyder, 1988, Novel antipsychotic drugs share high affinity for σ receptors, Eur. J. Pharmacol. 155, 345.
14. 2 binding in rat brain, Eur. J. Pharmacol. 259, 65.
15. Long, J.B., R.E. Tidwell, F.C. Tortella, K.C. Rice and B.R. De Costa, 1990, Selective sigma ligands protect against dynorphin A-induced spinal cord injury in rats, Soc. Neurosci. Abstr. 16, 1122.
16. Martin, W.R., C.E. Eades, J.A. Thompson and R.E. Huppler, 1976, The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197, 517.
17. Matsumoto, R.R., M.K. Hemstreet, N.L. Lai, A. Thurkauf, B.R. De Costa, K.C. Rice, S.B. Hellewell, W.D. Bowen and J.M. Walker, 1990, Drug specificity of pharmacological dystonia, Pharmacol. Biochem. Behav. 36, 151.
18. Matsumoto, R.R., W.D. Bowen, M.A. Tom, V.N. Vo, D.D. Truong and B.R. De Costa, 1995, Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism, Eur. J. Pharmacol. 280, 301.
19. 1 sites, Eur. J. Pharmacol. 301, 31.
20. 1 receptor agonists and neurosteroids attenuate β[25-35]-amyloid peptide-induced amnesia in mice through a common mechanism, Soc. Neurosci. Abstr. 22, 787.8.
21. 3 dorsal hippocampus by sigma ligands, J. Pharmacol. Exp. Ther. 261, 123.
22. Pontecorvo, M.J., E.W. Karbon, S. Goode, D.B. Clissold, S.A. Borosky, R.J. Patch and J.W. Ferkany, 1991, Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents, Brain Res. Bull. 26, 461.
23. Rao, T.S., J.A. Cler, S.J. Mick, V.M. Dilworth, P.C. Contreras, S. Iyengar and P.L. Wood, 1990, Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vitro, Neuropharmacology 29, 1191.
24. Ross, S.B., 1991, Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450, Pharmacol. Toxicol. 68, 293.
25. Rowland, L.P., 1985, Blood-brain barrier, cerebrospinal fluid, brain edema, and hydrocephalus, in: Principles of Neural Science, 2nd edn., eds. E.R. Kandel and J.H. Schwartz (Elsevier, New York) p. 839.
26. Salisbury, J.L., J.S. Condeelis and P. Satir, 1983, Receptor-mediated endocytosis: machinery and regulation of the clathrin-coated vesicle pathway, Int. Rev. Exp. Pathol. 24, 1.
27. 3H]3-PPP binding to σ sites in rat brain, Eur. J. Pharmacol. 165, 335.
28. Schwartz, A.L., 1995, Receptor cell biology: receptor-mediated endocytosis, Pediatr. Res. 38, 835.
29. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain, J. Pharmacol. Exp. Ther. 223, 284.
30. Su, T.-P., E.D. London and J.H. Jaffe, 1988, Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems, Science 240, 219.
31. 3H]haloperidol binding in guinea pig brain membranes, Proc. Natl. Acad. Sci. USA 81, 5618.
32. Vilner, B.J. and W.D. Bowen, 1995, Dual modulation of cellular calcium by sigma receptor ligands: release from intracellular stores and blockade of voltage-dependent influx, Soc. Neurosci. Abstr. 21, 631.3.
33. Vilner, B.J., B.R. De Costa and W.D. Bowen, 1995, Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability, J. Neurosci. 15, 117.
34. Walker, J.M., R.R. Matsumoto, W.D. Bowen, D.L. Gans, K.D. Jones and F.O. Walker, 1988, Evidence for a role of haloperidol-sensitive σ-'opiate' receptors in the motor effects of antipsychotic drugs, Neurology 38, 961.
35. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B. De Costa and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
36. 2 receptors in motor function, Eur. J. Pharmacol. 231, 61.
37. Yamamoto, H., T. Yamamoto, A. Baba, E. Takamori, Y.L. Murashima and S. Okuyama, 1995, Internalization of sigma (σ)-1 receptors into the primary cultured neuronal cells, Soc. Neurosci. Abstr. 21, 636.9.
38. 3H]azidoNE-100 in the primary cultured neuronal cells and the PC-12 cells, Soc. Neurosci. Abstr. 22, 787. 2.